deltatrials
Completed PHASE4 NCT00655109

A Comparison of Olopatadine and Fluticasone in Patients With Allergic Conjunctivitis

A Comparison of Olopatadine Versus Fluticasone Nasal Spray in the Prevention of the Signs and Symptoms of Allergic Conjunctivitis

Sponsor: Greiner, Jack V., OD DO PhD

Conditions Conjunctivitis, Allergic
Interventions Artificial tears Fluticasone Olopatadine Saline
Updated 4 times since 2017 Last updated: Apr 2, 2008 Started: Feb 29, 2008 Primary completion: Mar 31, 2008 Completion: Mar 31, 2008

Listed as NCT00655109, this PHASE4 trial focuses on Conjunctivitis, Allergic and remains completed. Sponsored by Greiner, Jack V., OD DO PhD, it has been updated 4 times since 2008, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Change History

4 versions recorded

  1. Sep 2024 — Present [monthly]

    Completed PHASE4

  2. Jul 2024 — Sep 2024 [monthly]

    Completed PHASE4

  3. Jan 2021 — Jul 2024 [monthly]

    Completed PHASE4

  4. Jan 2017 — Jan 2021 [monthly]

    Completed PHASE4

    First recorded

Feb 2008

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Greiner, Jack V., OD DO PhD
Data source: Greiner, Jack V., OD DO PhD

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

  • • North Andover, United States